Ukrainian Pharma: challenges and opportunities Pharmaceutical Industry Review, special issue, December 2022
strongly depends on import. There were logistic problems with raw materials supply. Besides instable currency exchange rate also had a negative influence on the prices. However, in January-February Darnitsa prepared certain stock of raw materials that enabled the company to work without stops. In March we manufactured 60% of the amount produced in pre-war time, while in April we managed to reach the pre-war level. Safety of people is our constant priority. Personnel working in the office immediately started to work online. For many years Darnitsa worked on processes automation, so we were prepared for this mode. During the war it was one of the critical component of the foundation for company’s controlled management. Company apply remote and hybrid modes of work – where it’s possible – and at the moment about 10% of employees remain abroad or moved to western Ukraine where they continue to work remotedly. No plan and no automation could help if there is no support from the team. Emotional support from the management was extremely important for employees. The war is absolutely not standard situation which directly influences basic human need of safety. Leadership team took the responsibility not only for business targets but for employees’ psychological condition as well. We gave them time and opportunity to think about safety, both personal and family, and to come back to resource status. Undoubtedly top managers became the role models: they were 24/7 accessible, ready to support team members by all available means. For a long time Darnitsa considers its employees to be the source of valuable knowledge which are adapted and deeply integrated into the business. This attitude did not change during the full scale war. We understand the importance of retention of the team consisting
38 BACK TO CONTENTS
of the best specialists, thus we did not cut any vacancy and did not reduce salaries. On the contrary, we had new openings for specialists in chemistry and manufacturing. However, during the war business faces not only the problem of jobs retention. The issue of quick personnel adaptation to business requirements during the war is very complicated. Thus we had the task to provide our team with new focal points and opportunities – and not only to retain it. Darnitsa’ All- Ukrainian call center which was opened at the beginning of the war is an example of such re- orientation. Country’s independence, national security consists of many components including pharmaceutical independence. Ukrainian pharmaceutical manufacturing is able to guarantee it by supplying army and civil population with major part of necessary medicines. At the moment according to the data
of research company Proxima Research Ukrainian pharma producers supply 65% of the medicines consumption market and produce 61% of the medicines included in the National medicines list. Two out of top three pharma market leaders are Ukrainian companies. There are 113 pharmaceutical manufacturing facilities in our country, many of them are equipped at the highest international level. Available manufacturing and research facilities, as well as highly skilled personnel, enable quick expansion of medicines variety within the framework of state-private partnership and state purchases. This will strengthen stability of healthcare system under the conditions of cataclysm and environmental deviations. Every year Darnitsa invest about 10% of its revenues in development, mainly fixed assets, digitalization and R&D of new medicines.
www.promoboz.com
www.promoboz.com |
www.cphem.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68
